SCHRODER INVESTMENT MANAGEMENT GROUP

Position in EXEL — Exelixis, Inc.

CIK 1086619 London, X0

Position in EXEL

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$36,400,560

+$13,860,451 QoQ

Shares Held

669,005

+27.3% QoQ

Ownership

0.270%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#57

of 739 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SCHRODER INVESTMENT MANAGEMENT GROUP holds $692,439,062 across 60 Biotechnology names. EXEL ranks #3 (5.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TECH	BIO-TECHNE Corp	1,410,943	$99,683,122
2	VRTX	Vertex Pharmaceuticals Inc / Ma	169,270	$84,081,485
3	EXEL	Exelixis, Inc. This page	669,005	$36,400,560
4	INSM	INSMED Inc	298,372	$31,812,422
5	ALNY	Alnylam Pharmaceuticals, Inc.	95,194	$28,656,248
6	MDGL	Madrigal Pharmaceuticals, Inc.	51,630	$27,722,728
7	VERA	Vera Therapeutics, Inc.	510,787	$21,917,869
8	TVTX	Travere Therapeutics, Inc.	379,611	$21,565,700

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$36,400,560	669,005	+27.3%	Shares	Sole	2026-08-13
2026-03-31	$22,540,109	525,533	+6.7%	Shares	Sole	2026-05-14
2025-12-31	$21,580,881	492,377	-12.9%	Shares	Sole	2026-02-13
2025-09-30	$23,359,897	565,615	-32.8%	Shares	Sole	2025-11-13
2025-06-30	$37,098,784	841,624	+18.9%	Shares	Sole	2025-08-13
2025-03-31	$26,127,434	707,677	+26.6%	Shares	Sole	2025-05-13
2024-12-31	$18,607,972	558,798	+87.6%	Shares	Sole	2025-02-12
2024-09-30	$7,729,414	297,858	+122981.8%	Shares	Sole	2024-11-13
2021-12-31	$4,423	242	+70.4%	Shares	Sole	2022-02-14
2021-09-30	$3,001	142	0.0%	Shares	Sole	2021-11-12
2021-06-30	$2,587	142	-65.3%	Shares	Sole	2021-08-13
2021-03-31	$9,239	409	-99.8%	Shares	Sole	2021-05-28
2020-06-30	$4,924,435	207,432	+1140.9%	Shares	Sole	2020-08-13
2020-03-31	$287,849	16,716	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.